Poop pills to treat brain fog in the ICU?

NCT ID NCT07348471

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether fecal microbiota transplantation (FMT) can help treat delirium in intensive care unit (ICU) patients. Delirium is a sudden confusion that affects up to 80% of ICU patients and has no proven drug treatment. The trial will give 60 patients either standard care or FMT via a feeding tube for three days, and track how many days they are free of delirium.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fecal microbiota transplantation (FMT)
What this could lead to
If it works, this could offer a new treatment for ICU delirium, a common and serious complication with no proven drug therapy.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply widely. FMT also carries risks like infection or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    RECRUITING

    Wuhan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.